BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:[ U.S. CDMRP – Melanoma Research Program Technology Development 
 Partnership Award | Research Funding ]
DTSTART;VALUE=DATE:20200622
DTSTAMP:20260407T074601Z
UID:d268bfae2b7a8f70632f51105d09f3496d2d4ccd78d1fec2974105ac
CATEGORIES:Call for proposal
DESCRIPTION:Aim: Through the Congressionally Directed Medical Research Pro
 gram (CDMRP)\, the Department of Defense is announcing the Melanoma Resear
 ch Program (MRP) Awards. The MRP Technology Development Partnership Award 
 is designed to encourage investigations into emerging technologies to assi
 st in the detection\, diagnosis\, prognosis\, and ultimately treatment of 
 melanoma. The intent of the TDPA is to foster collaboration between biomed
 ical sciences and physical sciences (e.g.\, bioengineering\, computational
  science\, imaging science\, and bioinformatics) and spur progress in the 
 development of computational approaches\, bioinformatics\, devices\, or kn
 owledge based products or outcomes\, etc.\n\nThe critical components of th
 is award mechanism are as follows:\n\n	Impact: The TDPA is intended to sup
 port research that demonstrates the potential to have a major impact on pa
 tient outcomes.\n	Preliminary Data: The TDPA is intended to support cross-
 disciplinary investigations that advance the melanoma research field forwa
 rd by utilizing previous research findings.\n	Cross-Disciplinary Personnel
  and Collaboration: The success of the project depends on the unique skill
 s and contributions of each collaborator. One PI must be from the biomedic
 al field and one PI must be from a physical science field.\n	Technological
  Design: The technological design of the research should integrate tenets 
 from a biomedical field with a physical science field. Techniques ranging 
 from fields such as quantitative science\, mathematics\, computer science\
 , or engineering\, may be merged with biomedical sciences to answer a spec
 ific need in the study of melanoma (diagnostics\, high risk markers\, dorm
 ancy\, and metastasis).\n\n\nFunding:        max. $700’000\n\nDura
 tion:      3 years\n\nEligibility: Applicants from international organ
 izations or institutions are eligible to apply\, and there are no citizens
 hip restrictions. The PI must have a faculty level appointment or equivale
 nt.\n\nHow to Apply: Pre-applications are submitted through the eBRAP plat
 form. They should contain contact information\, a preproposal narrative\, 
 and a list of collaborators and key personnel as suggested on the platform
 . Full applications (by invitation) will be made via a Grants.gov workspac
 e. Full application packages can be downloaded from Grants.gov at any time
 .\n\nPre-Application Deadline: 22-June-2020\, 5:00 p.m. EST\nFull Applicat
 ion Deadline: 24-September-2020\, 11:59 p.m. EST\n\nGrants.gov Funding Opp
 ortunity Number: W81XWH-20-MRP-TDPA\n\nFurther information\n\n\n	To see th
 e program announcement\, navigate to the search page on Grants.gov and sea
 rch for the Opportunity Number W81XWH-20-MRP-TDPA\n	For questions about th
 e eBRAP or Grants.gov platforms\, contact the Research Office.\n
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR